| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8441769 | European Journal of Cancer | 2015 | 7 Pages |
Abstract
The CCP score is an independent prognostic marker in early stage lung adenocarcinoma. The prognostic score provides superior risk estimates than stage alone. The threefold higher risk in the high-risk group defines a subset of patients that should consider therapeutic choices to improve outcome.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Emad Rakha, Maria J. Pajares, Marius Ilie, Ruben Pio, Jose Echeveste, Elisha Hughes, Irshad Soomro, Elodie Long, Miguel A. Idoate, Susanne Wagner, Jerry S. Lanchbury, David R. Baldwin, Paul Hofman, Luis M. Montuenga,